Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer’s disease via activation of adenosine A1 receptor
Yanying Kong, Qiuju Peng, Nan Lv, et al.
Neuroscience Letters (2020) Vol. 730, pp. 135016-135016
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment
Yasaman Esmaeili, Zahra Yarjanli, Fatemeh Pakniya, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 147-175
Closed Access | Times Cited: 119
Genus Paeonia monoterpene glycosides: A systematic review on their pharmacological activities and molecular mechanisms
Shiyi Xu, Huiyan Cao, Rui-hong Yang, et al.
Phytomedicine (2024) Vol. 127, pp. 155483-155483
Closed Access | Times Cited: 17
Behaviour Hallmarks in Alzheimer’s Disease 5xFAD Mouse Model
Mafalda Soares Pádua, José Luis Guil‐Guerrero, Paula A. Lopes
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6766-6766
Open Access | Times Cited: 16
The multifaceted mechanisms of Paeoniflorin in the treatment of tumors: State-of-the-Art
Xue Zhen Wang, Lei Xia, Xiaoyu Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112800-112800
Open Access | Times Cited: 48
Visuo‐spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer's disease: Effects of age, sex, albinism, and motor impairments
Timothy P. O’Leary, Richard E. Brown
Genes Brain & Behavior (2022) Vol. 21, Iss. 4
Open Access | Times Cited: 42
The potential role of plant secondary metabolites on antifungal and immunomodulatory effect
Xuedong Zhou, Meng Zeng, Fujiao Huang, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 14, pp. 4471-4492
Open Access | Times Cited: 25
A review for the pharmacological effects of paeoniflorin in the nervous system
Hongxiang Hong, Xu Lu, Chunshuai Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28
A network pharmacology approach to reveal the key ingredients in Scrophulariae Radix (SR) and their effects against Alzheimer's disease
Yingying Shi, Zhongqiang Chen, Lixia Huang, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24785-e24785
Open Access | Times Cited: 6
Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin
Chengying Shen, Baode Shen, Jun-Jun Zhu, et al.
Drug Development and Industrial Pharmacy (2020) Vol. 47, Iss. 2, pp. 207-214
Closed Access | Times Cited: 41
Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis
Wei Peng, Yunhui Chen, Steve Tumilty, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 97-102
Closed Access | Times Cited: 35
Mechanisms of mitophagy and oxidative stress in cerebral ischemia–reperfusion, vascular dementia, and Alzheimer’s disease
Yu-Jie Lyu, Zhipeng Meng, Yun‐Yun Hu, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Recent Insights Into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases
Feng Jiao, Kevin Varghese, Shaoxun Wang, et al.
Journal of Cardiovascular Pharmacology (2021) Vol. 77, Iss. 6, pp. 728-734
Open Access | Times Cited: 32
Pathway-based network medicine identifies novel natural products for Alzheimer’s disease
Yumei Liang, Siqi Xie, Jianping Jia
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Paeoniflorin ameliorates cognitive impairment in Parkinson’s disease via JNK/p53 signaling
Zhu-qing He, Peng-fei Huan, Li Wang, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 4, pp. 1057-1070
Open Access | Times Cited: 17
Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8
Zhiyue Li, Qiang Zeng, Shengquan Hu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Paeoniflorin ameliorates oxaliplatin-induced peripheral neuropathy via inhibiting neuroinflammation through influence on gut microbiota
Jiayue Xu, Langqing Lu, Shiqin Jiang, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176516-176516
Closed Access | Times Cited: 3
Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes
Gabriela Nogueira Debom, Dominique S. Rubenich, Elizandra Braganhol
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 13
Yuan-Zhi decoction in the treatment of Alzheimer’s disease: An integrated approach based on chemical profiling, network pharmacology, molecular docking and experimental evaluation
Qiong Wu, Xiang Li, Xiaowen Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Review on dietary supplements as an effective improvement of Alzheimer’s disease: focus on structures and mechanisms
Sheng Li, Yinling Wei, Zhenzhen Liang, et al.
Deleted Journal (2023) Vol. 13, Iss. 4, pp. 1787-1805
Open Access | Times Cited: 5
Network pharmacology and in vivo studies reveal the neuroprotective effects of paeoniflorin on Alzheimer's disease
Mengyuan Zhang, Haoran Zheng, Jiale He, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21800-e21800
Open Access | Times Cited: 5
A Review of Traditional Chinese Medicine, Buyang Huanwu Decoction for the Treatment of Cerebral Small Vessel Disease
Liying Sun, Xuhui Ye, Linlin Wang, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 8
Drug delivery targets and strategies to address mast cell diseases
Clayton H. Rische, Ariel Helms Thames, Rebecca A. Krier-Burris, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 2, pp. 205-222
Open Access | Times Cited: 4
Paeoniflorin exerts anti-PTSD effects in adult rats by modulating hippocampus and amygdala histone acetylation modifications in response to early life stress
Hanfang Xu, Tiange Zhang, Ling Li, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111035-111035
Closed Access | Times Cited: 1
Cholinesterase Inhibitory Activity of Paeoniflorin: Molecular Dynamics Simulation, and In Vitro Mechanistic Investigation
Mohnad Abdalla, Asaad Khalid, Jasmine Hedayati, et al.
Biochemistry Research International (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
<p>Research Progress on Classical Traditional Chinese Medicine Jieyu Pills in the Treatment of Depression</p>
Yuan Wang, Miao Peng
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 3023-3033
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top